As it was shown for COVID-19 infection that levels of IL-6, along with IL-8 and TNF-α, were powerful predictors of severity and survival at the time of hospitalization [70], using IL-6 inhibitors could be a promising therapy against sever COVID-19. Here, IL6 is linked to COVID-19.